OGI
Organigram Global Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Strong sell
-66/100
Last price
0.98
▲ 0.04 (4.47%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.96
Prev close
0.94
Day high
0.99
Day low
0.93
Volume
418.11K
Market cap
$139.84M
P/E (TTM)
2.26
52W range
0.85 – 2.24
Day trading desk
Gap from prior close
+2.45%
Prior close 0.94
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
1.97%
0.96 – 0.98
Position in range
100%
Near session high
ATR (14D)
0.05
4.90% of price
Prior day high
0.96
PDH
Prior day low
0.92
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 881.49K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-9.35%
-11.3%
1M
-16.02%
-17.2%
3M
-0.21%
-4.7%
6M
-29.20%
-47.4%
YTD
-42.26%
-56.5%
1Y
-48.40%
-64.8%
3Y
-26.52%
-108.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on OGI open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
43.79M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 20, 26 | Hansel (Finn A) Senior Officer of Issuer |
— | 0 | — | Direct |
| May 22, 26 | Yamanaka (James Hideo) Director of Issuer |
BUY | 20.00K | $15.92K | Direct |
| May 14, 26 | Guyatt (Gregory) Senior Officer of Issuer |
BUY | 10.00K | $11.08K | Direct |
| Apr 15, 26 | British American Tobacco Plc 10% Security Holder of Issuer |
BUY | 2.10M | $4.58M | Indirect |
| Mar 26, 26 | Machum (Donald Geoffrey) Director of Issuer |
— | 700 | — | Direct |
| Mar 26, 26 | Machum (Donald Geoffrey) Director of Issuer |
SELL | 700 | $947 | Direct |
| Mar 26, 26 | Machum (Donald Geoffrey) Director of Issuer |
— | 100 | — | Direct |
| Mar 26, 26 | Machum (Donald Geoffrey) Director of Issuer |
SELL | 100 | $134 | Direct |
| Mar 26, 26 | Machum (Donald Geoffrey) Director of Issuer |
— | 400 | — | Direct |
| Mar 26, 26 | Machum (Donald Geoffrey) Director of Issuer |
SELL | 400 | $546 | Direct |
| Mar 26, 26 | Machum (Donald Geoffrey) Director of Issuer |
— | 400 | — | Direct |
| Mar 26, 26 | Machum (Donald Geoffrey) Director of Issuer |
SELL | 400 | $544 | Direct |
| Mar 26, 26 | Machum (Donald Geoffrey) Director of Issuer |
— | 200 | — | Direct |
| Mar 26, 26 | Machum (Donald Geoffrey) Director of Issuer |
SELL | 200 | $273 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
British American Tobacco Plc |
10% Security Holder of Issuer | — | Acquisition or disposition carried out privately |
De Luca (Paolo CPA) |
Senior Officer of Issuer | 49.20K | Exercise of rights |
Emberg (Timothy) |
Senior Officer of Issuer | 59.13K | Exercise of rights |
Goldenberg (Beena) |
Senior Officer of Issuer | 146.19K | Exercise of rights |
Guyatt (Gregory) |
Senior Officer of Issuer | 27.36K | Acquisition or disposition in the public market |
Hansel (Finn A) |
Senior Officer of Issuer | 1.20M | Opening Balance-Initial SEDI Report |
Kubrick (Nathalie Anne Belisle) |
Senior Officer of Issuer | 28.38K | Exercise of rights |
Martin (Helen) |
Senior Officer of Issuer | 60.68K | Exercise of rights |
McFadden (Katrina May) |
Senior Officer of Issuer | 46.12K | Exercise of rights |
Mccrae (Megan Amber) |
Senior Officer of Issuer | 31.83K | Exercise of rights |
Fundamentals
Market cap$139.84M
Enterprise value$227.83M
Revenue (TTM)$309.18M
Gross profit$112.98M
EBITDA$16.43M
Net income$86.62M
EPS (TTM)$0.43
Free cash flow$-1.25M
Total cash$11.67M
Total debt$31.65M
Book value / share$2.61
Shares outstanding144.15M
Float97.33M
Short % of float—
Dividend yield0.00%
Beta (5Y)1.91
Valuation & profitability ratios
Trailing P/E2.26
Forward P/E40.42
PEG ratio—
Price / sales—
Price / book0.37
EV / revenue0.74
EV / EBITDA13.87
Gross margin36.54%
Operating margin5.04%
Profit margin28.02%
Return on equity17.56%
Return on assets-0.60%
Debt / equity5.69
Current ratio2.61
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2022 | YoY |
|---|---|---|---|---|
| Total revenue | $259.18M | $159.84M | $145.81M | +62.2% |
| Operating revenue | $402.88M | $247.08M | $208.99M | +63.1% |
| Cost of revenue | $168.97M | $112.32M | $114.24M | +50.4% |
| Gross profit | $90.22M | $47.52M | $31.57M | +89.8% |
| Research & development | $10.95M | $11.20M | $5.96M | -2.3% |
| Selling, general & admin | $86.88M | $67.23M | $59.21M | +29.2% |
| Total operating expense | $105.52M | $82.28M | $70.32M | +28.2% |
| Operating income | -$15.30M | -$34.76M | -$38.75M | +56.0% |
| Net interest income | — | — | -$429.00K | — |
| Pre-tax income | -$38.53M | -$45.44M | -$14.37M | +15.2% |
| Tax provision | -$13.77M | $0 | -$88.00K | — |
| Net income | -$24.76M | -$45.44M | -$14.28M | +45.5% |
| Net income to common | -$24.76M | -$45.44M | -$14.28M | +45.5% |
| Basic EPS | -0.19 | -0.48 | -0.19 | +59.3% |
| Diluted EPS | -0.19 | -0.48 | -0.19 | +59.3% |
| EBIT | -$15.30M | -$34.76M | -$13.94M | +56.0% |
| EBITDA | $2.67M | -$22.68M | $10.96M | +111.8% |
| Basic shares | 127.67M | 95.29M | 77.23M | +34.0% |
| Diluted shares | 127.67M | 95.29M | 77.23M | +34.0% |
| Line item | 2025 | 2024 | 2022 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $28.20M | $106.75M | $68.52M | -73.6% |
| Cash & short-term investments | $29.03M | $107.57M | $98.61M | -73.0% |
| Accounts receivable | $63.59M | $32.66M | $43.86M | +94.7% |
| Inventory | $123.95M | $82.52M | $68.28M | +50.2% |
| Total current assets | $284.90M | $262.22M | $221.62M | +8.6% |
| Property, plant & equipment | $122.98M | $96.23M | $259.82M | +27.8% |
| Goodwill & intangibles | $101.03M | $8.09M | $56.24M | +1,148.6% |
| Total assets | $562.21M | $407.86M | $577.11M | +37.8% |
| Total current liabilities | $126.16M | $53.32M | $55.28M | +136.6% |
| Current debt | $25.00K | $60.00K | $80.00K | -58.3% |
| Long-term debt | — | $25.00K | $155.00K | — |
| Total debt | $8.75M | $4.46M | $3.36M | +96.5% |
| Total liabilities | $213.08M | $101.87M | $69.05M | +109.2% |
| Retained earnings | -$608.73M | -$583.97M | -$289.93M | -4.2% |
| Shareholder equity | $349.13M | $305.99M | $508.06M | +14.1% |
| Working capital | $158.74M | $208.90M | $166.34M | -24.0% |
| Net tangible assets | $248.09M | $297.90M | $451.82M | -16.7% |
| Shares issued | 134.46M | 108.59M | 78.45M | +23.8% |
| Line item | 2025 | 2024 | 2022 | YoY |
|---|---|---|---|---|
| Net income | -$24.76M | -$45.44M | -$14.28M | +45.5% |
| Depreciation & amortisation | $17.98M | $12.08M | $24.91M | +48.8% |
| Stock-based compensation | $4.22M | $7.18M | $5.13M | -41.3% |
| Change in working capital | -$2.12M | $14.96M | -$22.88M | -114.2% |
| Operating cash flow | -$7.59M | $3.87M | -$36.21M | -296.0% |
| Capital expenditure | -$17.05M | -$5.34M | -$48.78M | -219.4% |
| Investing cash flow | -$81.07M | -$30.80M | $44.03M | -163.2% |
| Dividends paid | — | — | $0 | — |
| Financing cash flow | $39.33M | $107.78M | $5.33M | -63.5% |
| Free cash flow | -$24.64M | -$1.47M | -$84.99M | -1,580.8% |
| End cash position | $83.59M | $132.60M | $68.52M | -37.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $105.78M | $59.79M | $63.54M | $80.06M | $70.79M | — | +76.9% |
| Operating revenue | $145.01M | $93.17M | $97.22M | $123.19M | $110.12M | — | +55.6% |
| Cost of revenue | $64.36M | $43.39M | $40.22M | $48.22M | $44.65M | — | +48.3% |
| Gross profit | $41.42M | $16.41M | $23.32M | $31.84M | $26.15M | — | +152.5% |
| Research & development | $2.21M | $2.02M | $2.08M | $3.15M | $2.76M | — | +9.4% |
| Selling, general & admin | $26.51M | $22.01M | $22.43M | $25.31M | $23.24M | — | +20.5% |
| Total operating expense | $36.09M | $26.20M | $26.73M | $30.65M | $28.25M | — | +37.8% |
| Operating income | $5.33M | -$9.79M | -$3.42M | $1.19M | -$2.10M | — | +154.4% |
| Pre-tax income | $103.95M | -$921.00K | $19.97M | -$41.73M | -$16.20M | — | +11,386.4% |
| Tax provision | -$1.59M | $0 | — | -$3.76M | -$9.90M | -$106.00K | — |
| Net income | $105.54M | -$921.00K | $19.97M | -$37.96M | -$6.29M | — | +11,559.1% |
| Net income to common | $105.54M | -$921.00K | $19.97M | -$37.96M | -$6.29M | — | +11,559.1% |
| Basic EPS | 0.78 | -0.01 | 0.15 | — | -0.05 | 0.33 | +11,257.1% |
| Diluted EPS | 0.77 | -0.01 | 0.15 | — | -0.05 | 0.32 | +11,142.9% |
| EBIT | $5.33M | -$9.79M | -$3.42M | $1.19M | -$2.10M | — | +154.4% |
| EBITDA | $15.45M | -$4.76M | $1.56M | $6.15M | $2.68M | — | +424.7% |
| Basic shares | 135.13M | 131.57M | 134.93M | — | 133.91M | 129.05M | +2.7% |
| Diluted shares | 136.53M | 131.57M | 136.77M | — | 133.91M | 133.51M | +3.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $10.85M | $4.29M | $7.58M | $28.20M | $35.88M | — | +152.8% |
| Cash & short-term investments | $11.67M | $5.10M | $8.38M | $29.03M | $36.78M | — | +128.6% |
| Accounts receivable | $86.74M | $51.62M | $49.07M | $63.59M | $56.57M | — | +68.0% |
| Inventory | $165.06M | $135.16M | $132.71M | $123.95M | $125.19M | — | +22.1% |
| Total current assets | $280.09M | $250.09M | $256.55M | $284.90M | $277.78M | — | +12.0% |
| Property, plant & equipment | $121.15M | $120.84M | $123.48M | $122.98M | $123.54M | — | +0.3% |
| Goodwill & intangibles | $398.22M | $91.74M | $99.27M | $101.03M | $103.08M | — | +334.1% |
| Total assets | $820.26M | $521.31M | $530.67M | $562.21M | $564.62M | — | +57.3% |
| Total current liabilities | $107.28M | $88.75M | $94.05M | $126.16M | $107.28M | — | +20.9% |
| Current debt | — | — | $10.00K | $25.00K | $40.00K | $55.00K | — |
| Long-term debt | $17.61M | — | — | — | — | — | — |
| Total debt | $31.45M | $8.20M | $8.45M | $8.75M | $9.15M | — | +283.7% |
| Total liabilities | $334.80M | $149.50M | $161.22M | $213.08M | $179.12M | — | +123.9% |
| Retained earnings | -$484.14M | -$589.68M | -$588.76M | -$608.73M | -$570.76M | — | +17.9% |
| Shareholder equity | $485.46M | $371.81M | $369.46M | $349.13M | $385.50M | — | +30.6% |
| Working capital | $172.81M | $161.34M | $162.49M | $158.74M | $170.51M | — | +7.1% |
| Net tangible assets | $87.24M | $280.07M | $270.19M | $248.09M | $282.42M | — | -68.9% |
| Shares issued | 140.98M | 136.47M | 135.13M | 134.46M | 133.88M | — | +3.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $105.54M | -$921.00K | $19.97M | -$37.96M | -$6.29M | — | +11,559.1% |
| Depreciation & amortisation | $10.12M | $5.03M | $4.98M | $4.96M | $4.79M | — | +101.2% |
| Stock-based compensation | $1.21M | $728.00K | $770.00K | $947.00K | $1.01M | — | +66.6% |
| Change in working capital | -$10.46M | -$549.00K | -$16.27M | -$4.57M | $15.31M | — | -1,806.2% |
| Operating cash flow | -$4.30M | -$6.76M | -$16.01M | -$1.45M | $14.63M | — | +36.4% |
| Capital expenditure | — | -$246.00K | -$2.10M | — | -$9.63M | -$6.55M | — |
| Investing cash flow | -$124.06M | -$1.41M | -$4.34M | $214.00K | -$9.43M | — | -8,692.7% |
| Financing cash flow | $85.12M | -$451.00K | -$450.00K | -$565.00K | -$560.00K | — | +18,974.3% |
| Free cash flow | -$3.87M | -$7.01M | -$18.12M | -$688.00K | $5.00M | — | +44.8% |
| End cash position | $10.85M | $53.94M | $62.16M | $83.59M | $85.03M | — | -79.9% |
Options analytics
Put / call volume
14.00
Put-heavy session
Put / call open interest
1.21
Positioning, not flow
Max pain
1.00
+3.1% from spot
ATM implied vol
12.5%
Nearest strike to spot
Skew (10% OTM)
-12.5%
Calls bid over puts
Call volume
1
Contracts, this expiry
Put volume
14
Contracts, this expiry
Heaviest call OI
2.00
100 contracts
Heaviest put OI
1.00
146 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.00 | 0.55 | +23,906.0% |
| Mar 2026 | -0.00 | — | — |
| Dec 2025 | -0.01 | -0.01 | -79.4% |
| Sep 2025 | -0.01 | -0.20 | -2,827.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.01 | 3 | $120.65M | +50.7% |
| Next quarter | 0.01 | 1 | $111.46M | +75.4% |
| Current year | 0.44 | 1 | $349.76M | +34.9% |
| Next year | 0.02 | 1 | $458.07M | +31.0% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusBUY
Strong buy / Buy1 / 3
Hold1
Sell / Strong sell0 / 0
Held by insiders31.06%
Held by institutions6.54%
Institutions holding84
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.03
-4.80% from price
SMA 20
1.05
-7.83% from price
SMA 50
1.10
-12.12% from price
SMA 100
1.06
-7.54% from price
SMA 200
1.27
-23.86% from price
EMA 12
1.02
-4.05% from price
EMA 26
1.06
-7.76% from price
EMA 50
1.08
-9.37% from price
RSI (14)
35.0
Neutral
MACD (12,26,9)
-0.04
Hist -0.01
ATR (14)
0.05
4.95% of price
Realised vol 30D
36.8%
Annualised
Bollinger upper
1.16
20, 2σ
Bollinger lower
0.95
20, 2σ
50 / 200 cross
Death
1.10 vs 1.27
Trend bias
Below 200
-23.86%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.07
More volatile than market
Correlation to SPY
0.24
Largely independent
Realised vol 30D
36.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-58.7%
Peak to trough
Max drawdown 5Y
-91.2%
Peak to trough
ATR 14
0.05
4.95% of price
Beta (reported)
1.91
5Y monthly, from filing
Short interest
Shares short
4.87M
Prior 4.83M
Change vs prior
+0.9%
Shorts adding
% of float
—
—
% of shares out
3.38%
Against total outstanding
Days to cover
9.0
Crowded exit
Float
97.33M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:4
Split dateJul 7, 2023
SEC filings
Corporate Changes & Voting Matters
6-K · 2026-09-30
Corporate Changes & Voting Matters
6-K · 2026-09-03
Corporate Changes & Voting Matters
6-K · 2026-09-01
Corporate Changes & Voting Matters
6-K · 2026-08-20
Corporate Changes & Voting Matters
6-K · 2026-08-11
Corporate Changes & Voting Matters
6-K · 2026-08-04
Corporate Changes & Voting Matters
6-K · 2026-07-20
Corporate Changes & Voting Matters
6-K · 2026-05-12
Headlines
Organigram Global Targets Profitable Growth With Canada Focus and German Expansion
MarketBeat · 7d ago
Organigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on X
Business Wire · 7d ago
Organigram Global to Host 2026 OG Investor Session
Business Wire · 35d ago
Cannara Biotech Appoints Nicholas Fozard as CFO
MT Newswires · 36d ago
Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure
Business Wire · 48d ago
Organigram (OGI) Q3 2026 Earnings Call Transcript
Motley Fool · 50d ago
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive · 51d ago
Organigram Global Inc. Q3 2026 Earnings Call Summary
Moby · 56d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.